BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6131480)

  • 1. Neurotransmitters in Huntington's Chorea--a clinician's view.
    Bruyn GW
    Prog Brain Res; 1982; 55():445-64. PubMed ID: 6131480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electromyographic studies on Huntington's chorea].
    Muroga T; Mano T; Matsui T; Hirose K
    Rinsho Shinkeigaku; 1974 Jun; 14(6):489-95. PubMed ID: 4279157
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 4. Nursing care study - Huntington's chorea: a case for sensitive care.
    Thompson B
    Nurs Mirror; 1982 May; 154(18):57-61. PubMed ID: 6210894
    [No Abstract]   [Full Text] [Related]  

  • 5. Huntington's chorea.
    Small O
    Nurs Times; 1986 Apr 9-15; 82(15):32-3. PubMed ID: 2939398
    [No Abstract]   [Full Text] [Related]  

  • 6. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
    Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
    Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromyographic silent period after transcranial brain stimulation in Huntington's disease.
    Priori A; Berardelli A; Inghilleri M; Polidori L; Manfredi M
    Mov Disord; 1994 Mar; 9(2):178-82. PubMed ID: 8196679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease.
    Hennenlotter A; Schroeder U; Erhard P; Haslinger B; Stahl R; Weindl A; von Einsiedel HG; Lange KW; Ceballos-Baumann AO
    Brain; 2004 Jun; 127(Pt 6):1446-53. PubMed ID: 15090475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involuntary movements in chorea-acanthocytosis: a comparison with Huntington's chorea.
    Shibasaki H; Sakai T; Nishimura H; Sato Y; Goto I; Kuroiwa Y
    Ann Neurol; 1982 Sep; 12(3):311-4. PubMed ID: 6215892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basal ganglia lesions and neurotransmitters].
    Yoshida M
    Nihon Rinsho; 1978; 36(1):58-64. PubMed ID: 24766
    [No Abstract]   [Full Text] [Related]  

  • 12. [Central organization of transmitter systems].
    Cuénod M; Reubi JC
    Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):205-15. PubMed ID: 45340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
    Walsh FX; Bird ED; Stevens TJ
    Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Saccadic eye movements in extrapyramidal disorders and particularly in Huntington's disease].
    Roig C
    Neurologia; 2001 Feb; 16(2):57-62. PubMed ID: 11257930
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the striatum in rule application: the model of Huntington's disease at early stage.
    Teichmann M; Dupoux E; Kouider S; Brugières P; Boissé MF; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Brain; 2005 May; 128(Pt 5):1155-67. PubMed ID: 15788544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease: modeling the gait disorder and proposing novel treatments.
    Banaie M; Sarbaz Y; Gharibzadeh S; Towhidkhah F
    J Theor Biol; 2008 Sep; 254(2):361-7. PubMed ID: 18621402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease. Pathogenesis and management.
    Martin JB; Gusella JF
    N Engl J Med; 1986 Nov; 315(20):1267-76. PubMed ID: 2877396
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotransmitters and neurodegenerative disorders.
    Kanazawa I
    Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of metoclopramide in a subject at risk for Huntington's chorea].
    Nivelon-Chevallier A; Giroud M; Fabre JL; Putelat R; Escousse A
    J Genet Hum; 1985 Jun; 33(2):131-3. PubMed ID: 3160826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.